Mitoxantrone dihydrochloride

CAS号

70476-82-3

分子式

C22H30Cl2N4O6

主要靶点

Topoisomerase|PKC

仅限科研使用

Cat No : CM06710

Print datasheet

Synonyms

Endogenous Metabolite|HL60 cells|antitumor|Apoptosis|B-CLL cells|breast cancer|lymphocytes|MCF-7|leukaemia|Mitoxantrone|mitozantrone dihydrochloride|mitozantrone Dihydrochloride|Mitoxantrone 2HCl|Mitoxantrone dihydrochloride|Mitoxantrone Dihydrochloride|Mitoxantrone Hydrochloride|Mitoxantrone hydrochloride|mitozantrone|Mitozantrone|Inhibitor|inhibit|Orthopoxvirus|NSC301739|NSC-301739|NSC 301739|PKC|Protein kinase C|Topo II|Topoisomerase|米托蒽醌二盐酸盐|盐酸米托蒽醌



产品信息

CAS号 70476-82-3
分子式 C22H30Cl2N4O6
主要靶点 Topoisomerase|PKC
主要通路 DNA 损伤和修复|细胞骨架|表观遗传
分子量 517.4
纯度 100%, 此纯度可做参考,具体纯度与批次有关系,可咨询客服
储存条件 Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
别名 Endogenous Metabolite|HL60 cells|antitumor|Apoptosis|B-CLL cells|breast cancer|lymphocytes|MCF-7|leukaemia|Mitoxantrone|mitozantrone dihydrochloride|mitozantrone Dihydrochloride|Mitoxantrone 2HCl|Mitoxantrone dihydrochloride|Mitoxantrone Dihydrochloride|Mitoxantrone Hydrochloride|Mitoxantrone hydrochloride|mitozantrone|Mitozantrone|Inhibitor|inhibit|Orthopoxvirus|NSC301739|NSC-301739|NSC 301739|PKC|Protein kinase C|Topo II|Topoisomerase|米托蒽醌二盐酸盐|盐酸米托蒽醌

靶点活性

PKC:8.5 μM

体内活性

Methotrexate能够抑制嘌呤和嘧啶的从头合成,多胺的形成以及DNA、RNA、磷脂和蛋白质的转甲基作用。Methotrexate抑制胸苷酸合成酶,使细胞内胸苷酸不足,最终导致抗增殖的细胞毒性作用。Methotrexate通过主动转运或易化扩散进入细胞,在细胞内经过多聚谷氨酸化后,会抑制二氢叶酸还原酶和二氢叶酸转化为四氢叶酸。

体外活性

Methotrexate在小鼠气囊炎模型中,Methotrexate的IC50 为每周0.08 mg/kg.

溶解度

H2O:2.6 mg/mL (5.03 mM);DMSO:38.8 mg/mL (74.99 mM)

细胞实验

The human breast carcinoma cell lines MDA-MB-231 and MCF-7 are seeded in standard 96-well plates. One day after seeding, the culture medium is changed and replaced by medium containing different concentration of Mitoxantrone (10-5 to 5 μM) with or without DHA (30 μM) during 7 days. Viability of cells are measured as a whole by the tetrazolium salt assay[3].

参考文献

1.Seitz M. Curr Opin Rheumatol, 1999, 11(3), 226-232.
2.Hirata S, et al. Arthritis Rheum, 1989, 32(9), 1065-1073.
3.Segal R, et al. Semin Arthritis Rheum, 1990, 20(3), 190-200.
4.Genestier L, et al. J Clin Invest, 1998, 102(2), 322-328.
5.Cronstein BN, et al. J Clin Invest, 1993, 92(6):2675-2682.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
=
×
×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
×
=
×
C1   V1   C2   V2